Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
– Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and […]
NeoGames Announces Fourth Quarter and Full Year 2023 Results
– Full Year 2023 Revenues and Share of NPI Revenues Interest total $254.6 million –– Full Year 2023 Net Loss […]
Omega Flex, Inc. Announces Fourth Quarter 2023 Earnings
OMEGA FLEX, INC. (OFLX) For the Period Ended December 31, Twelve Months Three […]
TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively […]
Nanobiotix to Present at Upcoming Investor Conferences in March
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a […]
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
New nonclinical data strengthen evidence of individual contribution of IO102 and IO103 in controlling tumor growth NEW YORK, March 06, […]
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Reported $456.3 million in cash resources as of December 31, 2023, which when combined with certain anticipated regulatory milestone payments […]
Lulus Reports Fourth Quarter and Fiscal Year 2023 Results
Expanded Gross Margin in Fourth Quarter 2023 by 180 bps, compared to Fourth Quarter 2022 Grew Fiscal Year 2023 Net […]
Five Below, Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Earnings Release and Conference Call Date
PHILADELPHIA, PA, March 06, 2024 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, […]
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing […]
